Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RANI
#3481
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.72%
Monthly Change
-0.72%
6 month change
+140.35%
Year Change
-8.67%
Previous Close
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
Volume
19
Markets
US Stock Market
Healthcare
RANI
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
24.39 M
25.3 M
26.04 M
33.51 M
—
Valuation ratios
Enterprise value
3.17 B
1.18 B
682.83 M
312.74 M
—
Price to earnings ratio
—
-4.61
-2.53
-1.3
-3.62
Price to sales ratio
—
—
—
0.04
—
Price to cash flow ratio
—
-3.02
-1.68
-1.1
-3.24
Price to book ratio
—
3.81
6.68
19.58
16.66
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.28
0.59
0.82
1.48
Return on equity %
0.07
0.41
1.34
8.59
5.1
Return on invested capital %
4 359.55
3 939.3
895.26
523.42
—
Gross margin %
100
—
—
100
—
Operating margin %
1 899.12
—
—
5 186.19
—
EBITDA margin %
—
—
—
—
—
Net margin %
306.62
—
—
2 920.04
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
45.3
20.96
6.36
1.5
3.17
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0
—
0.02
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.27
0.42
0.26
0.64
Long term debt to total equity ratio
0
0.79
1.9
4.83
7.16
Per share metrics
Operating cash flow per share
—
1.95
2.01
1.25
0.81
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.27
0.23
0.13
0.8
Net current asset value per share
—
4.24
1.99
1.04
1.99
Tangible book value per share
—
1.55
0.5
0.07
0.48
Working capital per share
—
4.04
1.68
0.35
-0.29
Book value per share
—
1.55
0.5
0.07
0.48
News
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Rani Therapeutics director Imran Mir a buys $1.26 million in stock
Rani Therapeutics appoints new directors and closes private placement
Rani Therapeutics adds two biotech investors to board of directors
Rani Therapeutics closes $60.3 million private placement
South Cone investments sells Rani Therapeutics (RANI) shares for $15.7m
3 Penny Stocks to Watch Now, 10/22/25 - TipRanks.com